1. Home
  2. DCTH vs ARTNA Comparison

DCTH vs ARTNA Comparison

Compare DCTH & ARTNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • ARTNA
  • Stock Information
  • Founded
  • DCTH 1988
  • ARTNA 1905
  • Country
  • DCTH United States
  • ARTNA United States
  • Employees
  • DCTH N/A
  • ARTNA N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • ARTNA Water Supply
  • Sector
  • DCTH Health Care
  • ARTNA Utilities
  • Exchange
  • DCTH Nasdaq
  • ARTNA Nasdaq
  • Market Cap
  • DCTH 394.9M
  • ARTNA 345.3M
  • IPO Year
  • DCTH N/A
  • ARTNA 1996
  • Fundamental
  • Price
  • DCTH $10.96
  • ARTNA $33.75
  • Analyst Decision
  • DCTH Strong Buy
  • ARTNA
  • Analyst Count
  • DCTH 4
  • ARTNA 0
  • Target Price
  • DCTH $24.00
  • ARTNA N/A
  • AVG Volume (30 Days)
  • DCTH 710.7K
  • ARTNA 29.4K
  • Earning Date
  • DCTH 08-06-2025
  • ARTNA 08-12-2025
  • Dividend Yield
  • DCTH N/A
  • ARTNA 3.71%
  • EPS Growth
  • DCTH N/A
  • ARTNA 22.05
  • EPS
  • DCTH N/A
  • ARTNA 2.08
  • Revenue
  • DCTH $53,850,000.00
  • ARTNA $109,294,000.00
  • Revenue This Year
  • DCTH $162.10
  • ARTNA $7.82
  • Revenue Next Year
  • DCTH $32.97
  • ARTNA $3.54
  • P/E Ratio
  • DCTH N/A
  • ARTNA $15.93
  • Revenue Growth
  • DCTH 1068.87
  • ARTNA 8.31
  • 52 Week Low
  • DCTH $7.17
  • ARTNA $29.45
  • 52 Week High
  • DCTH $18.23
  • ARTNA $39.02
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 42.66
  • ARTNA 42.12
  • Support Level
  • DCTH $10.44
  • ARTNA $32.65
  • Resistance Level
  • DCTH $11.67
  • ARTNA $33.50
  • Average True Range (ATR)
  • DCTH 0.46
  • ARTNA 0.62
  • MACD
  • DCTH 0.11
  • ARTNA -0.05
  • Stochastic Oscillator
  • DCTH 68.03
  • ARTNA 20.51

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About ARTNA Artesian Resources Corporation

Artesian Resources Corp operates as a holding company with a focus on water distribution and wastewater services. Its regulated utility segment includes subsidiaries providing water and wastewater services in Delaware, Maryland, and Pennsylvania. Water distribution spans residential, commercial, industrial, and municipal sectors, while wastewater services are offered in Sussex County, Delaware. The company also engages in non-utility businesses, offering service line protection plans, engineering services, and contract operations for water and wastewater systems. The regulated utility segment constitutes the portion of the company's operations, subject to regulations by Delaware, Maryland, and Pennsylvania.

Share on Social Networks: